Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-22-004696
Filing Date
2022-02-17
Accepted
2022-02-17 14:45:06
Documents
1
Period of Report
2022-02-15

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 2064
  Complete submission text file 0001062993-22-004696.txt   3733
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Reporting) CIK: 0000882095 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38869 | Film No.: 22647403
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Issuer) CIK: 0001760542 (see all company filings)

EIN.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations